Skip to search.
 TSX Up 0.37% TSX Ventures  0.00%
Streaming
Ticker Tape: On

More On ONC.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Oncolytics Biotech, Inc. (ONC.TO)

-Toronto
1.75 Down 0.01(0.57%) Apr 17, 3:59PM EDT
Add to Portfolio
Prev Close:1.76
Open:1.85
Bid:1.74
Ask:1.84
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:1.72 - 1.85
52wk Range:1.54 - 3.62
Volume:29,733
Avg Vol (3m):59,506
Market Cap:148.41M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.29
Quarterly EPS Est (Mar-14) :-0.07
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback